Trial site
Sarah Cannon Research Institute SCRI
- 17running trials
- 1closed trial
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Chronic lymphocytic leukaemia3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Metastatic breast cancer3 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Colorectal cancer2 trials
- Mantle cell lymphoma2 trials
- Prostate cancer2 trials
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- and 8 more
- Phase
- Phase 18 trials
- Phase 37 trials
- Phase 1/23 trials
- Status
- Recruiting10 trials
- Active, not recruiting7 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Loxo Oncology, Inc.4 trials
- Day One Biopharmaceuticals, Inc.1 trial
- HiberCell, Inc.1 trial
- IDEAYA Biosciences1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Active, not recruiting
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Recruiting
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- Endometrial cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Ovarian cancer2 recruiting
- Prostate cancer2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026